|
|||||||||
|
|||||||||
Latest ArticlesThe FDA tasks the Reagan-Udall Foundation with a whitewash reviewSeptember 17, 2022 • Washington Examiner The Food and Drug Administration has problems in many of the product areas it oversees. These include the slow approval of drugs, unnecessary and prolonged shortages of infant formula, and the problematic, ineffective regulation of tobacco products. To his credit, FDA Commissioner Dr. Robert Califf seems to realize his agency has issues. He commissioned a report to recommend corrective actions. So far, so good.
FDA: Fix Department, ASAPSeptember 14, 2022 • Real Clear Policy Kudos to Food and Drug Administration Commissioner Dr. Robert Califf for acknowledging his agency needs help. Recognizing a problem is a prerequisite to making amends. On July 19th, Califf conceded, as only a government official could, "the agency has confronted a series of challenges that have tested our regulatory frameworks and stressed the agency's operations, prompting me to take a closer look at how we do business." He also commissioned a report to help figure things out. The FDA's bungled response to contamination at the Abbott Nutrition infant formula plant in Michigan drew attention to broader problems within the agency's food regulation bureaucracy.
Defying Markets to Promote Organics
|
Most Viewed
|
||||||||
home | biography | articles | blog | media coverage | spoken | audio/video | announcements | mailing list | mobile site |